Current Research Projects which include DIPR Registry Participation:
Ramon Rodriguez, MD
"A Pilot, Randomized, Double-Blind, Placebo-Controlled Phase I Study to Determine the Safety and Efficacy of Ampicillin in Treating Primary Dystonia Symptoms." University of Florida, Principal Investigator, Ramon Rodriguez, MD
The purpose of this study is to evaluate if the antibiotic Ampicillin is safe and tolerated in patients that have generalized dystonia caused by the DYT-1 gene mutation, as compared to patients treated with a placebo. A placebo is a pill that looks and tastes the same as the real drug, but without the active ingredient. The second objective of this study is to determine if dystonia symptoms improve while on the study drug.
Kristina Simonyan, MD PHD
"Structural Biomarkers of Primary Focal Dystonias". Mount Sinai Hospital, Principal Investigator, Kristina Simonyan, MD PHD
H.A. Jinnah, MD PHD
"Clinical Studies of Dystonia and Related Disorders (CSOD)". Emory, Principal Investigator, H.A. Jinnah, MD PHD